The coordinated investment supports research, clinical trials and manufacturing technologies to strengthen epidemic and pandemic preparedness. Funding is a research commitment, not evidence of vaccine efficacy, regulatory approval or availability to patients.
UK commits £33.2m to eight vaccine technology research projects
A £33.2 million government programme will support eight projects developing vaccine technologies against threats including Ebola, plague, Marburg, Lassa, Nipah, chikungunya and Mayaro.